▼ SELL
10b5-1 Plan
$ Value
$95K
Shares
28,298
Price
$3
Filed
Mar 11
Insider
Name
Khan Najat
Title
CEO and President
CIK
0002020969
Roles
Director
Officer
Transaction Details
Transaction Date
2026-03-09
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,262,085
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025 | This transaction was executed in multiple trades at prices ranging from $3.32 to $3.405. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Filing Info
Khan Najat's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-09 | RXRX | ▼ | $95K |
| 2026-02-17 | RXRX | F | $50K |
| 2026-02-06 | RXRX | A | $0 |
| 2026-02-06 | RXRX | A | $0 |
| 2026-02-06 | RXRX | F | $41K |
| 2025-12-22 | RXRX | ▼ | $549K |
| 2025-11-17 | RXRX | F | $73K |
| 2025-11-05 | RXRX | A | $0 |
| 2025-11-05 | RXRX | A | $0 |
| 2025-08-18 | RXRX | ▼ | $202K |
Other Insiders at RXRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Taylor Ben R
Chief Financial Officer
|
— | $68K | 2026-04-06 |
| Li Dean Y | — | — | 2026-04-01 |
| Dar Zavain | — | — | 2026-04-01 |
| Borgeson Blake | — | $1.6M | 2026-04-07 |
| Gibson Christopher | — | $557K | 2026-04-07 |
|
Hallett David
Chief Scientific Officer
|
— | — | 2026-02-17 |
|
Khan Najat
CEO and President
|
— | — | 2026-02-17 |